Healthcare Commercialization
Where Strategy Meets Commercial Impact
Founder & Managing Partner, Forward Ventures Group
Debra Richman helps healthcare companies and organizations, including private equity and venture-backed businesses, commercialize clinical and product potential, bringing market foresight, commercial strategy, and hands-on execution at critical inflection points.
DEBRA S. RICHMAN
Founder & Managing Partner, Forward Ventures Group
"The most important work in healthcare right now is building companies that deliver quality care sustainably with the right commercial model as the foundation."
Debra has developed commercial structures, accretive partnerships, pricing models, and analytics frameworks and built field operations supporting organizations at a national scale across Digital Health & AI, Value-Based Care, MedTech, Oncology, and Payors & Government Programs.
About Debra
A Rare Combination of Foresight & Execution
Having operated across multiple key sectors of the healthcare ecosystem, including payors, providers, investors, and operators, Debra understands each stakeholder’s objectives and knows how to align them around a commercial opportunity.
Debra works with private equity and venture-backed healthcare companies at critical commercial inflection points, from market entry and go-to-market strategy through revenue acceleration and investor readiness. She brings both the strategic perspective of an advisor and the execution capability of an operator.
- Founder & Managing Partner, Forward Ventures Group
- Board Director, Authentic Interactions, Inc.
- Advisor, Treehub
- Chief Development Officer, The Oncology Institute (now Starling Oncology, Nasdaq: STLN)
- Managing Director, Healthcare, Alvarez & Marsal
Services
Commercial Strategy for Healthcare Growth
Debra works with management teams at growth-stage companies to turn commercial strategy into execution: entering new markets, optimizing revenue, and building the go-to-market infrastructure that supports profitable and sustainable growth.
AI Commercialization & Adoption
Helping AI-enabled healthcare companies move from pilot to scale by solving the commercial challenges technology alone cannot answer. Market adoption, reimbursement pathways, and the provider and payor buy-in that turns capability into revenue.
Revenue Optimization
Identifying and removing the commercial barriers holding back growth. Pipeline architecture, pricing optimization, and field operations built for scale.
Partnership Strategy
Structuring and executing partnerships across payors, providers, and technology platforms that create sustainable competitive advantage and revenue.
Commercial Diligence
For private equity and venture investors evaluating healthcare opportunities. Independent assessment of market sizing, commercial model validity, and revenue potential.
Investor Readiness
Shaping the commercial narrative for fundraising and exit. Building the evidence base that demonstrates repeatable, scalable revenue growth to investors.
Post-Acquisition Value Creation
Driving commercial transformation in the critical 100 days and beyond: integrating capabilities, aligning teams, and capturing the value thesis.
Sector Expertise
Deep Expertise Across the Healthcare Ecosystem
Digital Health & AI
Supporting AI-enabled health technology companies, from diagnostics and clinical decision support to patient engagement and workflow transformation solutions.
Value-Based Care
Deep experience across value-based oncology, Medicare Advantage, primary care, and specialty models aligning payor, provider, and patient incentives around quality outcomes.
MedTech
Commercializing innovative medical technologies through strategic market positioning, go-to-market execution, provider adoption, and growth acceleration.
Oncology
Commercial growth and market expansion within value-based and community oncology, helping organizations scale access, optimize performance, and navigate complex provider ecosystems.
Payors & Govt. Programs
Developing value-add programs across Medicare Advantage and government programs, structuring accretive partnerships across provider and payor channels.
Engagement Models
Trusted Advisor to Management Teams and Investors
Debra typically works with companies that have proven technology or services and a clear need to accelerate commercial traction, working directly with leadership to drive the results that matter most.
Embedded Commercial Advisor
Working directly with management teams providing the strategic and functional depth needed to drive execution and accelerate growth without the need for a full-time executive hire.
Interim Commercial Executive
Serving as interim Chief Revenue, Chief Growth, or Chief Development Officer during a leadership gap or a period of transition, on a defined timeline.
Strategic Project Partner
Time-bound engagements focused on a specific commercial challenge: a new market entry, a pricing rethink, a partnership structure, or an investor narrative.
Investor Diligence Advisor
Supporting Private Equity and venture firms with independent commercial due diligence assessing market opportunity, business model validity, and revenue scalability.
Experience
A Record of Results
Founder & Managing Partner
Working with growth-stage healthcare companies at commercial inflection points, partnering closely with management teams to drive market entry, revenue acceleration, and investor readiness outcomes.
Board Director
Governance focus on commercialization strategy and capital formation for a pioneer in digital human technology and AI conversational video.
Advisor
Advising cohort companies on commercial strategy: go-to-market, reimbursement pathways, and payor and provider adoption. A Stanford-adjacent AI healthcare venture fund and residency program supporting scientist-builders creating health startups at the intersection of AI, science, and healthcare, backed by AI Health Fund.
Chief Development Officer
Led business and corporate development, M&A, and new market expansion for a national value-based oncology platform serving more than two million lives, delivering sustained double-digit revenue growth and margin expansion.
Managing Director, Healthcare
Advised Private Equity firms and corporate clients on commercial due diligence, business transformation, and post-acquisition value creation across the full healthcare ecosystem.
Common Questions
Frequently
Asked Questions
Have a different question? Reach out directly at debra@forwardventuresgroup.com
What types of companies do you work with?
Debra works primarily with growth-stage healthcare companies, typically Private Equity or venture-backed, that have proven technology or services and need to accelerate go-to-market and commercial traction. The healthcare sectors include Digital Health & AI, Value-Based Care, MedTech, Oncology, and Payors & Government Programs. She focuses on helping companies approaching critical growth inflection points.
How does an engagement typically work?
Engagements are structured around the specific need, from focused project-based work on a specific commercial challenge to embedded assistance with commercial and go-to-market execution. Debra embeds directly with management teams and brings both strategic perspective and functional execution capability.
Do you work with investors as well as portfolio companies?
Yes. Debra works with both Private Equity and venture firms on commercial due diligence and with portfolio companies on value creation post-acquisition. Her background spans both advisory and operational roles, giving her credibility and insight relevant to both sides of an investment.
What is your experience with AI in healthcare?
She serves on the Board of Directors of Authentic Interactions, Inc., an AI conversational video and digital human technology company, and is an Advisor to Treehub, a Stanford-adjacent AI healthcare venture fund and residency program backed by AI Health Fund, where she works with cohort companies on commercial strategy.
How do I start a conversation?
The best way to reach Debra is via email at debra@forwardventuresgroup.com or through LinkedIn. She welcomes direct, candid conversations about your commercial challenge, no lengthy intake process required.